NasdaqGM - Delayed Quote USD

Apogee Therapeutics, Inc. (APGE)

42.02
+1.89
+(4.71%)
At close: 4:00:01 PM EDT
42.02
0.00
(0.00%)
After hours: 4:04:11 PM EDT
All numbers in thousands
Download
Breakdown
12/31/2024
12/31/2023
12/31/2022
Total Assets
753,951
401,404
152,055
Total Liabilities Net Minority Interest
37,157
21,491
9,980
Total Equity Gross Minority Interest
716,794
379,913
142,075
Total Capitalization
716,794
379,913
142,075
Common Stock Equity
716,794
379,913
0
Capital Lease Obligations
11,831
2,034
0
Net Tangible Assets
716,794
379,913
0
Working Capital
501,153
377,851
142,075
Invested Capital
716,794
379,913
0
Tangible Book Value
716,794
379,913
0
Total Debt
11,831
2,034
0
Share Issued
59,478.73
48,519.33
48,017.62
Ordinary Shares Number
59,478.73
48,519.33
48,017.62
12/31/2022 - 7/14/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SYRE Spyre Therapeutics, Inc.
18.56
+8.16%
 
ANAB AnaptysBio, Inc.
23.97
+3.36%
 
LEGN Legend Biotech Corporation
37.64
+8.22%
 
SRRK Scholar Rock Holding Corporation
34.42
+1.03%
 
IMVT Immunovant, Inc.
16.74
+2.76%
 
ACLX Arcellx, Inc.
66.61
-0.37%
 
UPB Upstream Bio, Inc.
11.59
+2.66%
 
PTGX Protagonist Therapeutics, Inc.
56.37
+1.24%
 
CNTA Centessa Pharmaceuticals plc
12.12
+1.51%
 
PCVX Vaxcyte, Inc.
37.20
0.00%